Data on Novo Nordisk experimental weight-loss drug show mostly mild side effects

By Deena Beasley (Reuters) -Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that side effects were mainly mild-to-moderate and other outcome results, including blood sugar levels, were positive. The company had previously announced top-line results for the 68-week studies, which found that CagriSema led to…

Read More

Musk’s xAi increases yield offer on $5 billion debt raise, source says

NEW VIDEO: billion Unlocked for New “Elon Musk Weapon”   From $1.50 per share to $98.40 🤩 [sponsor] [adv] NEW VIDEO: $13 billion Unlocked for New “Elon Musk Weapon” [sponsor] Air Force Magazine calls it “transformational.” The Wall Street Journal calls it one of the Pentagon’s “highest priorities.” National Defense Magazine reports “Eye-popping budget” for it. This…

Read More

Kroger lifts sales target as cautious Americans buy cheaper groceries

By Juveria Tabassum (Reuters) -U.S. grocer Kroger bumped up its annual sales growth forecast on Friday and said it would invest in lowering prices to attract value-seeking consumers against a backdrop of tariff-induced uncertainty, sending its shares 7% higher. President Donald Trump’s sweeping tariffs have rattled global markets, raising fears of persistent inflation in the…

Read More

US sanctions target those providing Iran with defense machinery, Houthi oil trading

WASHINGTON (Reuters) -The Trump administration said on Friday it had issued fresh Iran-related sanctions targeting eight entities, one vessel and one person for their alleged role in providing sensitive machinery for Tehran’s defense industry. “The United States remains resolved to disrupt any effort by Iran to procure the sensitive, dual-use technology, components, and machinery that…

Read More